279 related articles for article (PubMed ID: 36941643)
81. Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.
Kim YJ; Kim JY; Kim Y; Lim YK; Jeong J; Jeong C; Kim M; Lim MC; Seo SS; Park SY
Strahlenther Onkol; 2016 Dec; 192(12):922-930. PubMed ID: 27734106
[TBL] [Abstract][Full Text] [Related]
82. The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience.
Yang T; Zhao T; Ji Z; Lei R; Qu A; Jiang W; Deng X; Jiang P
Radiat Oncol; 2024 Jun; 19(1):77. PubMed ID: 38909242
[TBL] [Abstract][Full Text] [Related]
83. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
[TBL] [Abstract][Full Text] [Related]
84. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.
Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618
[TBL] [Abstract][Full Text] [Related]
85. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
86. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
[TBL] [Abstract][Full Text] [Related]
87. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
[TBL] [Abstract][Full Text] [Related]
88. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
89. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
Paton AM; Chalmers KE; Coomber H; Cameron AL
Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
[TBL] [Abstract][Full Text] [Related]
90. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
Basu S; Manir KS; Basu A; Ghosh K
J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
[TBL] [Abstract][Full Text] [Related]
91. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance.
Lang S; Nesvacil N; Kirisits C; Georg P; Dimopoulos JC; Federico M; Pötter R
Radiother Oncol; 2013 Apr; 107(1):26-31. PubMed ID: 23541645
[TBL] [Abstract][Full Text] [Related]
92. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
93. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
94. [MRI based 3D brachytherapy planning of the cervical cancer - our experiences with the use of the uterovaginal Vienna Ring MR CT applicator].
Vojtíšek R; Mouryc F; Cechová D; Ciprová R; Ferda J; Fínek J
Klin Onkol; 2014; 27(1):45-51. PubMed ID: 24635437
[TBL] [Abstract][Full Text] [Related]
95. Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.
Kaliyaperumal V; Banerjee S; Kataria T; Abraham SK; Kamaraj D; Tamilselvan S; Gupta D; Bisht SS; Narang K; Shishak S
J Med Phys; 2022; 47(4):322-330. PubMed ID: 36908497
[TBL] [Abstract][Full Text] [Related]
96. High-Dose-Rate Three-Dimensional Image-Guided Adaptive Brachytherapy (3D IGABT) for Locally Advanced Cervical Cancer (LACC): A Narrative Review on Imaging Modality and Clinical Evidence.
Wang K; Wang J; Jiang P
Curr Oncol; 2023 Dec; 31(1):50-65. PubMed ID: 38275830
[No Abstract] [Full Text] [Related]
97. Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.
Kirisits C; Federico M; Nkiwane K; Fidarova E; Jürgenliemk-Schulz I; de Leeuw A; Lindegaard J; Pötter R; Tanderup K
Radiother Oncol; 2015 Dec; 117(3):548-54. PubMed ID: 26316396
[TBL] [Abstract][Full Text] [Related]
98. Uncertainties of deformable image registration for dose accumulation of high-dose regions in bladder and rectum in locally advanced cervical cancer.
Jamema SV; Mahantshetty U; Andersen E; Noe KØ; Sørensen TS; Kallehauge JF; Shrivastava SK; Deshpande DD; Tanderup K
Brachytherapy; 2015; 14(6):953-62. PubMed ID: 26489919
[TBL] [Abstract][Full Text] [Related]
99. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Sturdza A; Pötter R; Fokdal LU; Haie-Meder C; Tan LT; Mazeron R; Petric P; Šegedin B; Jurgenliemk-Schulz IM; Nomden C; Gillham C; McArdle O; Van Limbergen E; Janssen H; Hoskin P; Lowe G; Tharavichitkul E; Villafranca E; Mahantshetty U; Georg P; Kirchheiner K; Kirisits C; Tanderup K; Lindegaard JC
Radiother Oncol; 2016 Sep; 120(3):428-433. PubMed ID: 27134181
[TBL] [Abstract][Full Text] [Related]
100. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.
Pötter R; Tanderup K; Kirisits C; de Leeuw A; Kirchheiner K; Nout R; Tan LT; Haie-Meder C; Mahantshetty U; Segedin B; Hoskin P; Bruheim K; Rai B; Huang F; Van Limbergen E; Schmid M; Nesvacil N; Sturdza A; Fokdal L; Jensen NBK; Georg D; Assenholt M; Seppenwoolde Y; Nomden C; Fortin I; Chopra S; van der Heide U; Rumpold T; Lindegaard JC; Jürgenliemk-Schulz I;
Clin Transl Radiat Oncol; 2018 Feb; 9():48-60. PubMed ID: 29594251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
